← USPTO Patent Grants

Anti-IL-5 antibodies

Grant US12577298B2 Kind: B2 Mar 17, 2026

Assignee

CEPHALON LLC

Inventors

Mark Terence Liddament, Anthony Doyle, Adam Clarke, David Jose Simon Laine, Bridget Ann Cooksey

Abstract

Disclosed herein are fully human antibody molecules that immunospecifically bind to human IL-5. The antibody molecules can bind to human IL-5 with an equilibrium affinity constant (KD) of at least about 40 pM as determined by surface plasmon resonance.

CPC Classifications

C07K 16/244 C07K 2317/92 C07K 2317/24 C07K 2317/56 C07K 2317/565 A61K 2039/505

Filing Date

2021-07-26

Application No.

17385532

Claims

12